van den Besselaar Anton M H P, van Vlodrop Iris J H, Berendes Paul B, Cobbaert Christa M
Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands.
Department of Clinical Chemistry, Albert Schweitzer Hospital, Dordrecht, The Netherlands.
Thromb Res. 2014 Jul;134(1):187-91. doi: 10.1016/j.thromres.2014.04.016. Epub 2014 Apr 26.
Conventional Vacutainer® Sodium Citrate blood collection tubes contain a relatively high concentration of contaminating magnesium ions, which may result in shortening of the prothrombin time (PT) and the International Normalized Ratio (INR). Recently the manufacturer of Vacutainer® Sodium Citrate tubes introduced new tubes with a magnesium-poor stopper. The magnesium concentration in the new low-Mg tubes is significantly lower than that in the conventional plastic tubes. The purpose of the present study was to compare PT and INR determined in specimens drawn with the new tubes to those drawn with the conventional tubes.
Venous blood specimens were collected from 22 healthy persons and 65 patients treated with vitamin K-antagonists using conventional Vacutainer® Sodium Citrate tubes and new, low-Mg Vacutainer® tubes. PT and INR were determined with four thromboplastin reagents, i.e., three brands of recombinant human tissue factor and one brand of combined rabbit brain reagent. Magnesium concentrations were determined in the citrate plasmas with a colorimetric method.
The differences in PT, INR and International Sensitivity Index (ISI) between the two tubes were significant when using three recombinant human thromboplastin reagents, but were not significant when using the rabbit thromboplastin. The PT and INR differences between the tubes correlated with the magnesium concentration differences (P<0.001). The INR bias between the four reagents was greater for specimens drawn with conventional tubes than the INR bias for specimens drawn with the new tubes.
Agreement of INR between reagents is improved by using magnesium-poor tubes.
传统的枸橼酸钠真空采血管(Vacutainer®)含有相对较高浓度的污染性镁离子,这可能导致凝血酶原时间(PT)和国际标准化比值(INR)缩短。最近,Vacutainer®枸橼酸钠管的制造商推出了带有贫镁塞子的新采血管。新型低镁采血管中的镁浓度明显低于传统塑料管中的镁浓度。本研究的目的是比较用新型采血管采集的标本与用传统采血管采集的标本所测定的PT和INR。
使用传统的Vacutainer®枸橼酸钠管和新型低镁Vacutainer®管,从22名健康人和65名接受维生素K拮抗剂治疗的患者中采集静脉血标本。使用四种凝血活酶试剂测定PT和INR,即三种品牌的重组人组织因子和一种品牌的兔脑组合试剂。用比色法测定枸橼酸血浆中的镁浓度。
使用三种重组人凝血活酶试剂时,两种采血管之间的PT、INR和国际敏感指数(ISI)差异显著,但使用兔凝血活酶时差异不显著。采血管之间的PT和INR差异与镁浓度差异相关(P<0.001)。对于用传统采血管采集的标本,四种试剂之间的INR偏差大于用新型采血管采集的标本的INR偏差。
使用贫镁采血管可改善试剂之间INR的一致性。